{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:30:14Z","timestamp":1790872214151,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":46,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000171.pub2","type":"reference-entry","created":{"date-parts":[[2004,1,29]],"date-time":"2004-01-29T18:02:36Z","timestamp":1075399356000},"source":"Crossref","is-referenced-by-count":28,"title":["Treatment of latent tuberculosis infection in HIV infected persons"],"prefix":"10.1002","author":[{"given":"Jimmy","family":"Volmink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Woldehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,1,26]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD000171.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00042560-200111010-00018","article-title":"No effect of isonizid prophylazis for purified protein derivative-negative HIV infected adults living in a country endemic tuberculosis: results of a randomized trial","volume":"28","author":"Fitzgerald","year":"2001","journal-title":"Journal of Acquuired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD000171.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199707313370505","article-title":"A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis","volume":"337","author":"Gordin","year":"1997","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000171.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-Infected persons. An international randomized trial","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"},{"issue":"9105","key":"10.1002\/14651858.CD000171.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomized trial of isoniazid verusu risampicine and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD000171.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00002030-199707000-00006","article-title":"Isoniazid preventive therapy for tuberculosis in HIV-1 infected adults: results of a randomized controlled trial","volume":"11","author":"Hawken","year":"1997","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000171.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200111090-00009","article-title":"Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults","volume":"15","author":"Johnson","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000171.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200111090-00009","article-title":"Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults","volume":"15","author":"Johnson","year":"2001","journal-title":"AIDS"},{"issue":"5","key":"10.1002\/14651858.CD000171.pub2-BIB8|cit8","first-page":"161","article-title":"Evaluation of 2 tuberculosis chemoprohylaxis regimens in patients infected with human immunodeficiency virus. The Gecmei Group","volume":"115","author":"Martinez","year":"2000","journal-title":"Medicina Clinica (Barcelona)"},{"key":"10.1002\/14651858.CD000171.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice weekly tuberculosis preventive therapy in HIV infection in Zambia","volume":"12","author":"Mwinga","year":"1998","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000171.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","article-title":"Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection","volume":"342","author":"Pape","year":"1993","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD000171.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002030-200101260-00011","article-title":"Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian Adults","volume":"15","author":"Quigley","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000171.pub2-BIB12|cit12","series-title":"9th Conf. of Retroviruses and Opportunistic Infections","first-page":"(Poster) 625-W","article-title":"A randomized trial of 3 regimens to prevent tuberculosis in anergic patients infected with HIV","author":"Rivero","year":"2002"},{"key":"10.1002\/14651858.CD000171.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus","volume":"337","author":"Whalen","year":"1997","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000171.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus.","volume":"337","author":"Whalen","year":"1997","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000171.pub2-BIB15|cit15","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(00)02870-1","volume":"356","author":"Fitzgerald","year":"2000","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD000171.pub2-BIB16|cit16","series-title":"IX International Conference on AIDS","article-title":"Compliance and side effects to chemoprophylaxis for TB in HIV+. Mexican experience","author":"Gracia","year":"1993"},{"key":"10.1002\/14651858.CD000171.pub2-BIB17|cit17","series-title":"12th World AIDS Conference","article-title":"Multinational study for preventive therapy of latent tuberculosis in HIV positive individuals: isoniazid vs. rifabutin","author":"Matteelli","year":"1998"},{"issue":"5","key":"10.1002\/14651858.CD000171.pub2-BIB18|cit18","article-title":"Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals","volume":"79","author":"Saenghirunvattana","year":"1996","journal-title":"J. Med Association Thai"},{"issue":"2","key":"10.1002\/14651858.CD000171.pub2-BIB19|cit19","first-page":"62","volume":"4","author":"Sanchez","year":"2002","journal-title":"Enf Emerg"},{"key":"10.1002\/14651858.CD000171.pub2-BIB20|cit20","series-title":"IX International Conference on AIDS","article-title":"Preventive tuberculosis chemotherapy with isonizid (INH) among patients infected with HIV-1","author":"Wadhawan","year":"1993"},{"key":"10.1002\/14651858.CD000171.pub2-BIB21|cit21","doi-asserted-by":"crossref","unstructured":"American Thoracic Society (ATS) Medical Section of the American Lung Association. Diagnostic standards and classification of tuberculosis Am Rev Resp Dis 1990 142","DOI":"10.1164\/ajrccm\/142.3.725"},{"issue":"5","key":"10.1002\/14651858.CD000171.pub2-BIB22|cit22","first-page":"381","article-title":"Mycobactrtium tuberculosis and HIV co-infection in the lung: synergic immune dysregulation leading to disease progression","volume":"55","author":"Bocchino","year":"2000","journal-title":"Mondaldi Arch Chest Dis"},{"issue":"4","key":"10.1002\/14651858.CD000171.pub2-BIB23|cit23","doi-asserted-by":"crossref","DOI":"10.1097\/00002030-199903110-00009","article-title":"soniazid prophylaxis for TB in HIV infection: a meta analysis of randomized controlled trials","volume":"13","author":"Bucher","year":"1999","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000171.pub2-BIB24|cit24","first-page":"1","article-title":"Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations","volume":"47","author":"CDC","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1002\/14651858.CD000171.pub2-BIB25|cit25","series-title":"Abstracts of the 9th Conference on Retrovirus and Opportunistic Infections","article-title":"Increased Risk of Tuberculosis Infection in HIV-Infected Patients with Severe Immunosuppression: a medical community response","author":"Cobo","year":"2002"},{"key":"10.1002\/14651858.CD000171.pub2-BIB26|cit26","first-page":"471","article-title":"Treatment of latent tuberculosis infection","volume-title":"Tuberculosis: A comprhensive international approach","author":"Cohn","year":"2000"},{"key":"10.1002\/14651858.CD000171.pub2-BIB27|cit27","first-page":"129","article-title":"Epidemiology of tuberculosis","volume-title":"Tuberculosis: A comprhensive international approach","author":"Comsock","year":"2000"},{"key":"10.1002\/14651858.CD000171.pub2-BIB28|cit28","first-page":"780","article-title":"How much isoniazid is needed for prophylaxis?","volume":"101","author":"Comstock","year":"1970","journal-title":"Am Rev Respir Dis"},{"key":"10.1002\/14651858.CD000171.pub2-BIB29|cit29","first-page":"187","article-title":"Immunology of Tuberculosis","volume-title":"Tuberculosis: A comprhensive international approach","author":"Daniel","year":"2000"},{"key":"10.1002\/14651858.CD000171.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000171.pub2-BIB31|cit31","first-page":"19","article-title":"The epidemiological basis of tuberculosis control","volume-title":"Clinical tuberculosis","author":"Enarson","year":"1994"},{"key":"10.1002\/14651858.CD000171.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.157.3.1271","article-title":"Effect of mycobacterium tuberculosis on HIV replication: role of immune activation","volume":"157","author":"Goletti","year":"1996","journal-title":"J Immunol"},{"key":"10.1002\/14651858.CD000171.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00002030-199310000-00007","article-title":"A prospective study of the risk of tuberculosis among HIV-infected patients","volume":"7","author":"Guelar","year":"1993","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000171.pub2-BIB34|cit34","first-page":"241","article-title":"The association between HIV and tuberculosis in the developing world","volume-title":"Clinical tuberculosis","author":"Harries","year":"1994"},{"key":"10.1002\/14651858.CD000171.pub2-BIB35|cit35","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","year":"1982","journal-title":"Bull WHO"},{"issue":"19","key":"10.1002\/14651858.CD000171.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM200005113421907","article-title":"Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection","volume":"342","author":"Kovacs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000171.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0962-8479(92)90033-G","article-title":"HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention","volume":"73","author":"Narain","year":"1992","journal-title":"Tuber Lung Dis"},{"key":"10.1002\/14651858.CD000171.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","article-title":"Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS","volume":"158","author":"Narita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/14651858.CD000171.pub2-BIB39|cit39","first-page":"151","article-title":"Preventive therapy for tuberculosis","volume-title":"Tuberculosis: back to the future","author":"O'Brien","year":"1994"},{"issue":"9","key":"10.1002\/14651858.CD000171.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/106002809603000901","article-title":"Low antituberculosis drug concentrations in patients with AIDS","volume":"30","author":"Peloquin","year":"1996","journal-title":"Ann Pharmacother"},{"issue":"13","key":"10.1002\/14651858.CD000171.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJM200103293441307","article-title":"Interactions among Drugs for HIV and Opportunistic Infections","volume":"344","author":"Piscitelli","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000171.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Eng J Med"},{"issue":"1","key":"10.1002\/14651858.CD000171.pub2-BIB43|cit43","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons (Cochrane Review)","author":"Smieja","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD000171.pub2-BIB44|cit44","first-page":"895","article-title":"Tuberculin reactivity and the risk of tuberculosis: a review.","volume":"4","author":"Watkins","year":"2000","journal-title":"Int J Tubercle & Lung Dis"},{"key":"10.1002\/14651858.CD000171.pub2-BIB45|cit45","unstructured":"World Health Organization (WHO) and UNAIDS Policy statement on preventive therapy against tuberculosis in people living with HIV: Report of a meeting held in Geneva, 18-20 February 1998 WHO\/TB\/98.255, UNAIDS\/98.34"},{"key":"10.1002\/14651858.CD000171.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.317.7159.625","article-title":"Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials","volume":"317","author":"Wilkinson","year":"1998","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000171.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000171.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T20:14:22Z","timestamp":1682626462000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000171.pub2"}},"subtitle":[],"editor":[{"given":"Sara","family":"Woldehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2004,1,26]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000171.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD000171.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2004,1,26]]}}}